Arsenic species that cause release of iron from ferritin and generation of activated oxygen

被引:173
作者
Ahmad, S
Kitchin, KT
Cullen, WR
机构
[1] US EPA, Natl Hlth & environm Effects Res Lab, Div Environm Carcinogenesis, Res Triangle Pk, NC 27711 USA
[2] Univ British Columbia, Dept Chem, Vancouver, BC, Canada
关键词
arsenic; dimethylarsinic acid; ferritin; iron; ascorbic acid; reactive oxygen species;
D O I
10.1006/abbi.2000.2023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The in vitro effects of four different species of arsenic (arsenate, arsenite, monomethylarsonic acid, and dimethylarsinic acid) in mobilizing iron from horse spleen ferritin under aerobic and anaerobic conditions were investigated. Dimethylarsinic acid (DMA((V))) and dimethylarsinous acid (DMA((III))) significantly released iron from horse spleen ferritin either with or without the presence of ascorbic acid, a strong synergistic agent. Ascorbic acid-mediated iron release was time-dependent as well as both (DMA((III))) and ferritin concentration-dependent. Iron release from ferritin by DMA((III)) alone or with ascorbic acid was not significantly inhibited by superoxide dismutase (150 or 300 units/ml). However, the iron release was greater under anaerobic conditions (nitrogen gas), which indicates direct chemical reduction of iron from ferritin by DMA((III)), with or without ascorbic acid. Both DMA((V)) and DMA((III)) released iron from both horse spleen and human liver ferritin. Further, the release of ferritin-iron by DMA((III)) with ascorbic acid catalyzed bleomycin-dependent degradation of calf thymus DNA. These results indicate that exogenous methylated arsenic species and endogenous ascorbic acid can cause (a) the release of iron from ferritin, (b) the iron-dependent formation of reactive oxygen species, and (c) DNA damage. This reactive oxygen species pathway could be a mechanism of action of arsenic carcinogenesis in man. (C) 2000 Academic Press.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 63 条
  • [11] SUPEROXIDE ION AS A PRIMARY REDUCTANT IN ASCORBATE-MEDIATED FERRITIN IRON RELEASE
    BOYER, RF
    MCCLEARY, CJ
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1987, 3 (06) : 389 - 395
  • [12] Brown JL, 1997, TERATOGEN CARCIN MUT, V17, P71, DOI 10.1002/(SICI)1520-6866(1997)17:2<71::AID-TCM3>3.3.CO
  • [13] 2-X
  • [14] Byrd DM, 1996, INT ARCH OCC ENV HEA, V68, P484
  • [15] THE REACTION OF METHYLARSENICALS WITH THIOLS - SOME BIOLOGICAL IMPLICATIONS
    CULLEN, WR
    MCBRIDE, BC
    REGLINSKI, J
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1984, 21 (03) : 179 - 194
  • [16] Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats
    Diwan, BA
    Kasprzak, KS
    Anderson, LM
    [J]. CARCINOGENESIS, 1997, 18 (09) : 1757 - 1762
  • [17] Double KL, 1998, J NEUROCHEM, V70, P2492
  • [18] SERUM FERRITIN LEVELS IN LUNG-CANCER PATIENTS
    FERRIGNO, D
    BUCCHERI, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 241 - 241
  • [19] ASCORBATE IS AN OUTSTANDING ANTIOXIDANT IN HUMAN-BLOOD PLASMA
    FREI, B
    ENGLAND, L
    AMES, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) : 6377 - 6381
  • [20] REDUCTIVE MOBILIZATION OF FERRITIN IRON
    FUNK, F
    LENDERS, JP
    CRICHTON, RR
    SCHNEIDER, W
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (01): : 167 - 172